News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
174,025 Results
Type
Article (12834)
Company Profile (23)
Press Release (161168)
Section
Business (48408)
Career Advice (610)
Deals (9062)
Drug Delivery (30)
Drug Development (27896)
Employer Resources (69)
FDA (4651)
Job Trends (3842)
News (90628)
Policy (7784)
Tag
2024 BioMidwest Digital (2)
2024 Bio NC Digital (1)
2024 Biotech Bay Standard (4)
2024 Biotech Beach Standard (1)
2024 Genetown Standard (2)
2024 Pharm Country Standard (2)
2026 Pharm Country Premier (1)
2026 Pharm Country Standard (1)
Academia (1067)
Academic (1)
Adcomms (6)
Allergies (28)
Alliances (13607)
ALS (34)
Alzheimer's disease (421)
Antibody-drug conjugate (ADC) (21)
Approvals (4651)
Artificial intelligence (54)
Autoimmune disease (5)
Automation (3)
Bankruptcy (70)
Best Places to Work (3194)
BIOSECURE Act (6)
Biosimilars (31)
Biotechnology (11)
Bladder cancer (18)
Brain cancer (7)
Breast cancer (70)
Cancer (483)
Cardiovascular disease (45)
Career advice (511)
Career pathing (13)
CAR-T (42)
Cell therapy (101)
Cervical cancer (7)
Clinical research (23604)
Collaboration (150)
Compensation (10)
Complete response letters (1)
COVID-19 (1076)
CRISPR (7)
C-suite (42)
Cystic fibrosis (19)
Data (606)
Denatured (6)
Depression (7)
Diabetes (82)
Diagnostics (1683)
Digital health (3)
Diversity (5)
Diversity, equity & inclusion (28)
Drug discovery (32)
Drug pricing (38)
Drug shortages (16)
Duchenne muscular dystrophy (23)
Earnings (14109)
Editorial (13)
Employer branding (5)
Employer resources (63)
Events (20634)
Executive appointments (158)
FDA (4920)
Featured Employer (10)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (2)
Frontotemporal dementia (1)
Funding (171)
Gene editing (14)
Generative AI (6)
Gene therapy (75)
GLP-1 (255)
Government (1163)
Grass and pollen (1)
Guidances (9)
Healthcare (5366)
Huntington's disease (6)
IgA nephropathy (7)
Immunology and inflammation (23)
Indications (6)
Infectious disease (1117)
Inflammatory bowel disease (52)
Inflation Reduction Act (4)
Influenza (13)
Intellectual property (13)
Interviews (104)
IPO (3414)
IRA (19)
Job creations (772)
Job search strategy (450)
Kidney cancer (2)
Labor market (5)
Layoffs (76)
Leadership (6)
Legal (1518)
Liver cancer (21)
Lung cancer (56)
Lymphoma (35)
Management (22)
Manufacturing (61)
MASH (29)
Medical device (3145)
Medtech (3147)
Mergers & acquisitions (5772)
Metabolic disorders (191)
Multiple sclerosis (31)
NASH (15)
Neurodegenerative disease (21)
Neuropsychiatric disorders (3)
Neuroscience (574)
NextGen: Class of 2025 (1994)
Non-profit (1631)
Northern California (447)
Obesity (89)
Opinion (45)
Ovarian cancer (9)
Pain (28)
Pancreatic cancer (17)
Parkinson's disease (47)
Partnered (6)
Patents (23)
Patient recruitment (27)
Peanut (16)
People (17159)
Pharmaceutical (11)
Pharmacy benefit managers (9)
Phase I (5235)
Phase II (10144)
Phase III (9618)
Pipeline (221)
Podcasts (9)
Policy (43)
Postmarket research (1147)
Preclinical (1878)
Press Release (29)
Prostate cancer (30)
Psychedelics (9)
Radiopharmaceuticals (62)
Rare diseases (93)
Real estate (1371)
Recruiting (23)
Regulatory (5662)
Reports (12)
Research institute (890)
Resumes & cover letters (82)
Rett syndrome (1)
RSV (16)
Schizophrenia (21)
Series A (42)
Series B (23)
Service/supplier (2)
Sickle cell disease (11)
Southern California (426)
Special edition (2)
Sponsored (4)
Startups (1177)
Stomach cancer (4)
Supply chain (12)
The Weekly (3)
United States (4272)
Vaccines (268)
Venture capitalists (8)
Webinars (5)
Weight loss (66)
Women's health (13)
Worklife (6)
Date
Today (37)
Last 7 days (164)
Last 30 days (720)
Last 365 days (8202)
2025 (1590)
2024 (8391)
2023 (9559)
2022 (12840)
2021 (14422)
2020 (14001)
2019 (13485)
2018 (10422)
2017 (9476)
2016 (9130)
2015 (10799)
2014 (7357)
2013 (5762)
2012 (6225)
2011 (6605)
2010 (5693)
Location
Africa (252)
Alabama (7)
Alaska (4)
Arizona (39)
Arkansas (2)
Asia (12417)
Australia (2383)
California (1049)
Canada (344)
China (127)
Colorado (49)
Connecticut (48)
Delaware (31)
Europe (33049)
Florida (150)
Georgia (66)
Idaho (14)
Illinois (128)
India (9)
Indiana (76)
Iowa (2)
Japan (57)
Kansas (27)
Kentucky (7)
Louisiana (4)
Maine (11)
Maryland (200)
Massachusetts (709)
Michigan (36)
Minnesota (80)
Missouri (15)
Montana (6)
Nebraska (6)
Nevada (16)
New Hampshire (10)
New Jersey (373)
New Mexico (7)
New York (418)
North Carolina (167)
Northern California (447)
Ohio (34)
Oklahoma (3)
Oregon (4)
Pennsylvania (259)
Puerto Rico (2)
Rhode Island (4)
South America (372)
South Carolina (6)
Southern California (426)
Tennessee (16)
Texas (127)
Utah (17)
Virginia (22)
Washington D.C. (6)
Washington State (150)
Wisconsin (9)
174,025 Results for "venturemed group".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
BioMidwest
VentureMed Receives Transitional Pass-through Payment (TPT) for FLEX Vessel Prep™ System
VentureMed Group, Inc. announced that the Center for Medicare & Medicaid Services has granted The FLEX Vessel Prep™ System a transitional pass-through payment category and a new HCPCS C-code effective January 1, 2024 and will remain in effect for the following two to three years.
November 8, 2023
·
2 min read
BioMidwest
VentureMed Group Raises Bridge Financing and Embarks on 2023 Objectives
VentureMed Group, Inc., a privately held medical device innovator in access management for arteriovenous fistulas and grafts and vessel preparation for interventional treatment of peripheral arterial disease announced that the company has raised bridge financing to support its 2023 objectives.
January 31, 2023
·
2 min read
Press Releases
VentureMed Completes Enrollment of the FLEX Vessel Prep™ System FLEX First AV Registry For The Treatment of Arteriovenous (AV) Access Management
July 30, 2024
·
3 min read
Press Releases
Pharming Group to participate in March 2025 investor conference
February 28, 2025
·
1 min read
Press Releases
Orion Group Financial Statement Release January–December 2024
February 25, 2025
·
16 min read
Press Releases
Pharming Group to participate in February 2025 investor conference
February 10, 2025
·
1 min read
Press Releases
Mario Biazzi, Founder of Dipharma Group, and His Contribution to the History of Nitroglycerin
February 24, 2025
·
2 min read
Press Releases
Stevanato Group Reports Record Revenue of €1,104 Million for Fiscal Year 2024
March 7, 2025
·
18 min read
Press Releases
Resource Label Group Expands into Quebec with the Acquisition of Imprimerie Ste-Julie
February 10, 2025
·
2 min read
Press Releases
Pharming Group to report fourth quarter and full year 2024 financial results on March 13
February 27, 2025
·
1 min read
1 of 17,403
Next
